Safety and antiviral activity of pradefovir in patients with chronic hepatitis B virus infection:: 48-week analysis of a phase 2 study

被引：0
|
作者：
Lim, S. G.
Lee, K. S.
Chuang, W. L.
Hwang, S. G.
Cho, M.
Lai, M. Y.
Chao, Y. C.
Chang, T. T.
Han, K. H.
Lee, C. M.
Um, S. H.
Yeon, J. E.
Yang, S. S.
Teo, E. K.
Peng, C. Y.
Lin, H. H.
Yang, S. S.
Huo, T. I.
Nguyen, T.
Chen, T. Y.
Hu, K. Q.
Xu, Y.
Sullivan-Bolyai, J. Z.
机构：
[1] Natl Univ Singapore Hosp, Coll Med, Singapore 117548, Singapore
[2] Yonsei Univ, Seoul, South Korea
[3] Kaohsiung Med Univ Hosp, Kaohsiung, Taiwan
[4] Bundang CHA Hosp, Kyonggi Do, South Korea
[5] Pusan Natl Univ Hosp, Pusan, South Korea
[6] Natl Taiwan Univ Hosp, Taipei, Taiwan
[7] Tri Serv Gen Hosp, Taipei, Taiwan
[8] Natl Cheng Kung Univ Hosp, Tainan 70428, Taiwan
[9] Kaohsiung Chang Gung Mem Hosp, Med Ctr Anam, Kaohsiung Hsien, Taiwan
[10] Korea Univ, Med Ctr Kuro, Seoul, South Korea
[11] Korea Univ, Seoul, South Korea
[12] Cathay Gen Hosp, Taipei, Taiwan
[13] Changi Gen Hosp, Singapore, Singapore
[14] China Med Univ Hosp, Taichung, Taiwan
[15] Tzu Chi Gen Hosp, Hualien, Taiwan
[16] Taichung Vet Gen Hosp, Taichung, Taiwan
[17] Taipei Vet Gen Hosp, Taipei, Taiwan
[18] Res & Educ Inc, San Diego, CA USA
[19] Chung Shan Med Univ Hosp, Taichung, Taiwan
[20] Univ Calif Irvine, Orange, CA 92668 USA
[21] Valeant Res & Dev, Costa Mesa, CA USA
来源：
JOURNAL OF CLINICAL VIROLOGY | 2006年 / 36卷
关键词：
D O I：
暂无
中图分类号：
Q93 [微生物学];
学科分类号：
071005 ; 100705 ;
摘要：
引用
收藏
页码：S238 / S238
页数：1
相关论文
共 50 条
  • [21] THERAPEUTIC EVALUATION OF TENOFOVIR ALAFENAMIDE IN THE TREATMENT OF CHRONIC HEPATITIS B PATIENTS WITH NORMAL ALANINE TRANSAMINASE AND POSITIVE HEPATITIS B VIRUS DNA: A 48-WEEK MULTICENTER RETROSPECTIVE STUDY FROM CHINA
    Yang, Yida
    Lian, Jiangshan
    Ye, Jin
    Song, Qirui
    Yang, Ling
    Yang, Ling
    Li, Jie
    Gao, Wenkang
    Deng, Qinzhi
    Du, Fan
    Lou, Jianjun
    Zhong, Jianfeng
    Tong, Zhaowei
    HEPATOLOGY, 2024, 80 : S181 - S182
  • [22] Safety, antiviral activity, and pharmacokinetics of rHSA/IFNα2a for treatment of chronic hepatitis B infection
    Zhang, Hong
    Wu, Min
    Li, Qingmei
    Li, Xiaojiao
    Ding, Yanhua
    Niu, Junqi
    HEPATOLOGY, 2015, 62 : 1211A - 1212A
  • [23] Evaluation of 48-week response of treatment-naive chronic hepatitis B patients to 0.5 mg/day entecavir
    Kolgelier, Servet
    Aktug Demir, Nazlim
    Ozcimen, Serap
    Sumer, Sua
    TURKISH JOURNAL OF MEDICAL SCIENCES, 2014, 44 (02) : 283 - 287
  • [24] B-Clear Phase 2b Study Design: Establishing the Efficacy and Safety of Bepirovirsen in Patients with Chronic Hepatitis B Virus Infection
    Jennifer Cremer
    Robert Elston
    Fiona M. Campbell
    Stuart Kendrick
    Melanie Paff
    Geoff Quinn
    Dickens Theodore
    Advances in Therapy, 2023, 40 : 4101 - 4110
  • [25] B-Clear Phase 2b Study Design: Establishing the Efficacy and Safety of Bepirovirsen in Patients with Chronic Hepatitis B Virus Infection
    Cremer, Jennifer
    Elston, Robert
    Campbell, Fiona M.
    Kendrick, Stuart
    Paff, Melanie
    Quinn, Geoff
    Theodore, Dickens
    ADVANCES IN THERAPY, 2023, 40 (09) : 4101 - 4110
  • [26] Impact of occult hepatitis B virus infection on antiviral therapy in chronic hepatitis C patients
    Elsawaf, Gamal El Din Ahmed
    Mahmoud, Ola Abd E. L. Kader
    Shawky, Sherine Mohamed
    Mohamed, Hanan Mostafa Mostafa
    Alsumairy, Hafez Hezam Ahmed
    ALEXANDRIA JOURNAL OF MEDICINE, 2015, 51 (03) : 241 - 246
  • [27] Occult Hepatitis B Virus Infection in Patients With Chronic Hepatitis C Treated With Antiviral Therapy
    Caviglia, Gian Paolo
    Abate, Maria Lorena
    Manzini, Paola
    Danielle, Franca
    Ciancio, Alessia
    Rosso, Chiara
    Olivero, Antonella
    Pellicano, Rinaldo
    Touscoz, Giovanni Antonio
    Smedile, Antonina
    Rizzetto, Mario
    HEPATITIS MONTHLY, 2012, 12 (11)
  • [28] TENOFOVIR ALAFENAMIDE FUMARATE IN TREATMENT- NAIVE CHRONIC HEPATITIS B PATIENTS WITH HISTOLOGICALLY CONFIRMED LIVER FIBROSIS: A 48-WEEK EFFICACY AND SAFETY RESULTS
    Zhou, Jialing
    Wu, Xiaoning
    Zhu, Chuanwu
    Zhang, Jiming
    Li, Ping
    Han, Tao
    Ding, Huiguo
    Liu, Chenghai
    Xie, Wen
    Xie, Qing
    Zong, Yali
    Meng, Tongtong
    Ou, Xiaojuan
    You, Hong
    Jia, Jidong
    HEPATOLOGY, 2023, 78 : S615 - S616
  • [29] Safety and efficacy of alamifovir in patients with chronic hepatitis B virus infection
    Soon, DKW
    Lowe, SL
    Teng, CH
    Yeo, KP
    McGill, J
    Wise, SD
    JOURNAL OF HEPATOLOGY, 2004, 41 (05) : 852 - 858
  • [30] A phase II study of the combination of histamine dihydrochloride and interferon alpha-2b (IFN-α-2B) as initial therapy in chronic hepatitis C (HCV) patients:: 48-week results
    Lurie, Y
    Hyle, S
    Gehlsen, KR
    GASTROENTEROLOGY, 2001, 120 (05) : A381 - A382
12345